Amiloride hydrochloride 5 MG Oral Tablet — RxCUI 977880
RxNorm drug concept · Semantic clinical drug
RxCUI 977880
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI977880
Official nameAmiloride hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asaMILoride HCl 5 MG Oral Tablet
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)20,737 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Amiloride: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's usually added to another diuretic for heart failure or high blood pressure. Its job is to keep your potassium from dropping too low, or bring it back up if it has.
- Take it by mouth with food, as your prescriber directs. It's normally added to your other diuretic. Your doctor may adjust it based on your blood tests.
- Most people tolerate it well. Some get nausea, appetite loss, gas, stomach pain, diarrhea, headache, dizziness, fatigue, muscle cramps or a mild rash.
- High potassium. It can be dangerous and may cause tingling, muscle weakness, tiredness or a slow heartbeat. Call your doctor right away if you notice these, and keep your blood-tes...
🕸️ Concept Web — How Amiloride hydrochloride 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Amiloride hydrochloride 5 MG Oral Tablet
RxCUI 977880 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Amiloride
644IN -
Amiloride hydrochloride
142424PIN
-
Amiloride
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Amiloride Oral Tablet
370564SCDF -
Amiloride hydrochloride Oral Tablet
2645556SCDFP -
Amiloride Oral Product
1151614SCDG -
Amiloride Pill
1151615SCDG -
Amiloride hydrochloride Oral Product
2659402SCDGP -
Amiloride hydrochloride Pill
2662461SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Amiloride Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Amiloride hydrochloride 5 MG
977879SCDC
-
Amiloride hydrochloride 5 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Amiloride hydrochloride 5 MG
SCDC · 977879 -
Amiloride Oral Tablet
SCDF · 370564 -
Amiloride hydrochloride Oral Tablet
SCDFP · 2645556 -
Amiloride Oral Product
SCDG · 1151614 -
Amiloride Pill
SCDG · 1151615 -
Amiloride hydrochloride Oral Product
SCDGP · 2659402 -
Amiloride hydrochloride Pill
SCDGP · 2662461
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
5 package NDCs map to RxCUI 977880 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-0292-01 | 100 TABLET in 1 BOTTLE (0574-0292-01) | amiloride hydrochloride | Padagis US LLC | 2009-04-06 |
| 42794-0005-02 | 100 TABLET in 1 BOTTLE (42794-005-02) | Amiloride Hydrochloride | Sigmapharm Laboratories, LLC | 2021-06-14 |
| 49884-0117-01 | 100 TABLET in 1 BOTTLE (49884-117-01) | Amiloride Hydrochloride | Endo USA, Inc. | 1986-05-12 |
| 49884-0117-10 | 1000 TABLET in 1 BOTTLE (49884-117-10) | Amiloride Hydrochloride | Endo USA, Inc. | 1986-05-12 |
| 63629-2114-01 | 1000 TABLET in 1 BOTTLE (63629-2114-1) | Amiloride Hydrochloride | Bryant Ranch Prepack | 1986-05-12 |
Observed labelers:
Endo USA, Inc. (2) ·
Bryant Ranch Prepack (1) ·
Padagis US LLC (1) ·
Sigmapharm Laboratories, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.